[Mechanisms of neurotransmitter release facilitation in strontium solutions].
Mechanisms of neurotransmitter release facilitation were studied using electrophysiological recording of end-plate currents (EPC) and nerve ending (NE) responses after substitution of extracellular Ca ions with Sr ions at the frog neuromuscular junction. The solutions with 0.5 mM concentration of Ca ions (calcium solution) or 1 mM concentration of Sr ions (strontium solution) were used where baseline neurotransmitter release (at low-frequency stimulation) is equal. Decay of paired-pulse facilitation of EPC at calcium solutions with increase of interpulse interval from 5 to 500 ms was well described by three-exponential function consisting of early, first and second components. Facilitation at strontium solutions was significantly diminished due mainly to decrease of early and first components. At the same time, EPC facilitation with rhythmic stimulation (10 or 50 imp/s) at strontium solutions was significantly increased. Also more pronounced decrease of NE response 3rd phase, reflecting potassium currents was detected under rhythmic stimulation of 50 imp/s at strontium solutions comparing to calcium solutions. It was concluded that facilitation sites underlying first and early components had lower affinity to Sr ions than to Ca ions. The enhancement of frequency facilitation at strontium solutions is mediated by two mechanisms: more pronounced broadening of NE action potential and increase of bivalent cation influx due to feebly marked activation of Ca(2+)-dependent potassium current by Sr ions, and slower dynamics of Sr(2+) removal from NE axoplasm comparing to Ca(2+).
M A
MA
Mukhamed'iarov
Iu O
IuO
Kochunova
E N
EN
Telina
A L
AL
Zefirov
D000109:Acetylcholine / Q000378:metabolism; D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D003470:Culture Media / Q000737:chemistry; D004558:Electric Stimulation; D009045:Motor Endplate / Q000378:metabolism / Q000502:physiology*; D009411:Nerve Endings / Q000378:metabolism / Q000502:physiology*; D018377:Neurotransmitter Agents / Q000378:metabolism*; D015221:Potassium Channels / Q000378:metabolism; D011895:Rana ridibunda; D012996:Solutions; D013324:Strontium / Q000378:metabolism* / Q000494:pharmacology; D046509:Tissue Culture Techniques / Q000379:methods
D003470:Culture Media; D018377:Neurotransmitter Agents; D015221:Potassium Channels; D012996:Solutions; D000109:Acetylcholine; D002118:Calcium; D013324:Strontium